Sapient Bioanalytics is an early-stage, fee-for-service contract research organization based in San Diego, California. It specializes in multi-omic biomarker discovery services aimed at accelerating drug development and advancing personalized medicine for pharmaceutical and biotech clients.
The company's technical capabilities span mass spectrometry, proteomics, metabolomics, lipidomics, cytokine profiling, and biocomputational services. Its central offering is the Integrated Biomarker Discovery Platform, which combines these analytical techniques with human health data to enable biomarker discovery at scale, linking biological targets, patient populations, and drug therapies.
Sapient Bioanalytics operates across several therapeutic areas, including oncology, cardiometabolic disease, neurodegeneration, immunology, and rare diseases. The organization works with clients ranging from pharmaceutical companies to biotech firms seeking to deepen their understanding of human biology through multi-omics studies.
